Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Telomir Pharmaceuticals Inc TELO

Healthcare Biotechnology
Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on reversing biological aging and degenerative diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Progeria, Wilson’s disease, and age-related macular degeneration (amd), as well as type 2 diabetes, cancer, and Alzheimer’s... see more

Current News (NDAQ:TELO)

Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Significantly Reduces PSA Levels in Human Prostate Cancer Cells

ACCESS Newswire 10 days ago

Telomir Pharmaceuticals Announces Telomir-1 Kills Aggressive Human Leukemia Cells

ACCESS Newswire November 21, 2025

Telomir Pharmaceuticals Reports Telomir-1 Outperforms FDA-Approved Gold-Standard Iron Chelator Deferoxamine (DFO) in Reducing Intracellular Iron in a Human Cell Line

ACCESS Newswire November 12, 2025

Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Resets Cancer's "Kill-and-Clean" Defense Systems in an Aggressive Prostate Cancer Model, Outperforming Rapamycin and Chemo

ACCESS Newswire October 23, 2025

Telomir Pharmaceuticals Executes Binding LOI for Worldwide Rights to Telomir-1, Positioning the Company for Global Market Expansion and Value Growth

ACCESS Newswire October 21, 2025

Telomir Pharmaceuticals Announces New Data Showing That Telomir-1 Kills Aggressive Pancreatic Cancer Cells, One of the Deadliest Forms of Cancer

ACCESS Newswire October 14, 2025

Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells

ACCESS Newswire October 9, 2025

Telomir Pharmaceuticals Announces New Findings in a Prostate Cancer Model Demonstrating Telomir-1 Also Resets DNA Methylation of Tumor Suppressor Genes Implicated in Two of the Most Persistent Challenges in Oncology-Metastasis and Treatment Resistance

ACCESS Newswire October 7, 2025

Telomir Pharmaceuticals Announces In Vitro Data Showing Telomir-1 Targets Additional Histone Demethylase Families, a Unique Profile in Cancer and Aging Not Seen in Other Therapies

ACCESS Newswire September 18, 2025
View More News ››

Opinion & Analysis (NDAQ:TELO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:TELO)

Buy buddy buy.

Otherwise it will be FOMO time for you fellas out there today anyway
coolfooldumbguy - November 21, 2025

Using technical analysis for this stock.

It is signalling strength to the upside for shareholders today,so good luck to all of you guys
coolfooldumbguy - October 23, 2025

Buy buddy buy.

Otherwise FOMO
coolfooldumbguy - October 7, 2025

Buy buddy buy because it's taking off this morning.

Otherwise FOMO for you fellas out there today
coolfooldumbguy - July 18, 2025

TELO...... On watch after ystrdys volume....$2.05

Double tapped alltime low then bounced . Cheers
Iseneschal - June 6, 2025

Magic pills to extend life

First trials on dogs have miraculous results. Some information on this company that is starting to get out there watch this https...
Patiencemyson - September 9, 2024
View more Bullboard ››

Forsys Metals Corp

Forsys Metals Corp

Forsys Metals Corp. together with its subsidiaries, engages in the acquisition, exploration, and development of uranium ...
View More »